We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

A new blood RNA test detects fallopian tube precancer and early ovarian cancer with 92% sensitivity and 98% specificity. More...
11 Nov 2026
Image: FDA approval enables the OncoMate MSI Dx Analysis System to identify patients who may benefit from Merck’s KEYTRUDA anti-PD-1 therapy. (Photo courtesy of Promega)

Microsatellite Instability Test Gains FDA Approval for Immunotherapy Selection

A new PCR-based test gains FDA approval to identify MSI-high solid tumors and help guide KEYTRUDA treatment. More...
11 Nov 2026
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

C2N Diagnostics and LSI Medience have partnered to seek approval and commercialize the PrecivityAD2 test in Japan. More...
11 Nov 2026
Graphical overview of the study design and colorectal cancer risk stratification using blood-detected mosaic chromosomal alterations (mCAs). The schematic summarizes mCA detection and genomic features, factors associated with mCA carriage, and the integration of mCAs with germline polygenic risk and lifestyle factors for colorectal cancer risk assessment. (Image Credit: ©Science Bulletin)

Blood-Detected Chromosomal Changes May Refine Colorectal Cancer Risk Assessment

New data show blood-detected mosaic chromosomal changes refine colorectal cancer risk stratification beyond genetics and lifestyle. More...
11 Nov 2026
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

A new multiplex PCR test gains CE-IVDR marking, enabling rapid single-sample detection of 13 respiratory pathogens. More...
11 Nov 2026
Image Credit: Adobe Stock

AI Tool Automates Variant Curation and Interpretation for Cancer Whole-Genome Sequencing

Inocras is presenting the first public results from its multimodal agentic AI framework at the AMP 2026 Annual Meeting & Expo. More...
11 Nov 2026
Image: Figure 1 from Lim J, et al. “Amplification of RNA for Identification of Zika and HCV in Whole Blood.” Science Advances, 2026. https://doi.org/10.1126/sciadv.aeb6129. Licensed under CC BY-NC 4.0. Created in BioRender: https://BioRender.com/mr4p5qy.

Portable Test Detects Zika and Hepatitis C RNA from Whole Blood

A new test detects Zika and HCV RNA directly from whole blood at point of care in hours without lab equipment. More...
11 Nov 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Urine Analyzer
respons® UDS100
Gold Member
Neonatal Heel Incision Device
Tenderfoot